Phase I study of gemcitabine and radiotherapy plus cisplatin after transurethral resection as conservative treatment for infiltrating bladder cancer. [electronic resource]
Producer: 20040108Description: 1310-6 p. digitalISSN:- 0360-3016
- Aged
- Carcinoma, Transitional Cell -- drug therapy
- Cisplatin -- administration & dosage
- Combined Modality Therapy
- Deoxycytidine -- administration & dosage
- Drug Administration Schedule
- Drug Therapy, Combination
- Female
- Humans
- Male
- Maximum Tolerated Dose
- Middle Aged
- Quality of Life
- Radiation-Sensitizing Agents -- administration & dosage
- Treatment Outcome
- Urinary Bladder Neoplasms -- drug therapy
- Gemcitabine
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article
There are no comments on this title.
Log in to your account to post a comment.